1. Home
  2. MRM vs CPIX Comparison

MRM vs CPIX Comparison

Compare MRM & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MRM

MEDIROM Healthcare Technologies Inc.

HOLD

Current Price

$2.10

Market Cap

15.8M

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$3.57

Market Cap

34.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRM
CPIX
Founded
2000
1999
Country
Japan
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.8M
34.1M
IPO Year
2020
2009

Fundamental Metrics

Financial Performance
Metric
MRM
CPIX
Price
$2.10
$3.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
88.8K
92.6K
Earning Date
05-22-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$55,915,220.00
$41,278,349.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$51.31
N/A
Revenue Growth
12.79
12.21
52 Week Low
$0.34
$1.85
52 Week High
$4.45
$7.25

Technical Indicators

Market Signals
Indicator
MRM
CPIX
Relative Strength Index (RSI) 48.89 76.73
Support Level $2.05 $2.42
Resistance Level $2.33 $2.73
Average True Range (ATR) 0.09 0.31
MACD 0.01 0.16
Stochastic Oscillator 36.11 91.38

Price Performance

Historical Comparison
MRM
CPIX

About MRM MEDIROM Healthcare Technologies Inc.

MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: